respiratory
Research

News in brief: Treprostinil benefit in IPF; Trucks bring sleep clinics to the bush; Gender disparity in citations a career barrier for female academics in medicine

Treprostinil benefit in IPF When used in patients with interstitial lung disease (ILD) and associated pulmonary hypertension, inhaled treprostinil  has most benefit in patients with idiopathic interstitial pneumonia and especially idiopathic pulmonary fibrosis, a study show. Sub-group analysis of  a phase 3 trial of treprostinil  compared to placebo in 326 patients  showed FVC differences of ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic